Firm involving high tech, life sciences and biotech

Austrianova is one organization that does businesses that comprises high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based business that associates in the insertion of living cells or bacteria in small pills for defense which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first formed in the year 2007 and was recognised in Singapore's top investigation biotech hub, Biopolis that has worldwide vision in offering encapsulation facilities like micro encapsulation.

There is a speedy moving topic of attention in healthy repair and more detailed, in the topic of neutraceuticals which is the knowing and use of probiotic bacteria. So, probiotics encapsulation was created. The cell-in-a-box technology was developed by Austranova with the target to protect, detach, contain and transport living cells. This great finding can be used for several reasons and can be operated to probiotics, cosmetics and agriculture environmental protection and screening as well as forming the foundation of a influential research gear.

In healthcare, this skill helps facilitates protected implantation of cells or stem cells such as cell therapy, combining them isolated from the immune system and permitting long stage construction of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure shields cells in bioreactors and fermentors and at the same time, it make easier refining of bioproducts created from the cells and it lessen constructing price too.

A gigantic rule cGMP facility for the production of biomedical grade encapsulated cell items was previously fruitfully established and right now, Austrianova is in the development of setting up this skill in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit lower doses of chemotherapy to be used more effectually without the casual enervating side consequences. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally alter a chemotherapeutic product to its tumor toxic product.

Come to our page for more information: Stem Cells, Capsules , Encapsulation Technology.